We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

4 hedge funds and large institutions have $4.15M invested in Intra-Cellular Therapies Inc. in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 389 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 395 → 4 (-391)

100% less capital invested

Capital invested by funds: $13.6B → $4.15M (-$13.6B)

100% less funds holding in top 10

Funds holding in top 10: 52 → 0 (-52)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 389

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
-391
Holders Change %
-98.99%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-52
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
389
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.26B
2
BlackRock
BlackRock
New York
-$1.15B
3
PCM
Pentwater Capital Management
Florida
-$685M
4
HI
HBK Investments
Texas
-$578M
5
Norges Bank
Norges Bank
Norway
-$472M
Name Holding Trade Value Shares
Change 		Change in
Stake
BTI
351
Blue Trust Inc
Georgia
– -$15.7K -119 Closed
SAM
352
Sherman Asset Management
California
– -$14.5K -110 Closed
TPCW
353
TD Private Client Wealth
New York
– -$13.5K -102 Closed
DB
354
Danske Bank
Denmark
– -$13.2K -100 Closed
PPC
355
Park Place Capital
Alabama
– -$12.9K -98 Closed
Fifth Third Bancorp
356
Fifth Third Bancorp
Ohio
– -$12K -91 Closed
TC
357
Truvestments Capital
Florida
– -$11.7K -89 Closed
BI
358
Binnacle Investments
Iowa
– -$11.1K -84 Closed
FFO
359
Fortitude Family Office
Arizona
– -$9.76K -74 Closed
ANBT
360
American National Bank & Trust
Texas
– -$6.2K -47 Closed
AT
361
Avalon Trust
New Mexico
– -$5.94K -45 Closed
WWM
362
Wolff Wiese Magana
California
– -$4.22K -32 Closed
AW
363
Avion Wealth
Texas
– -$2K -25 Closed
SS
364
SBI Securities
Japan
– -$3.3K -25 Closed
HFS
365
Hughes Financial Services
Virginia
– -$3.17K -24 Closed
BOJHT
366
Bank of Jackson Hole Trust
Wyoming
– -$2.82K -22 Closed
BIA
367
Bell Investment Advisors
California
– -$2.9K -22 Closed
OP
368
ORG Partners
Indiana
– -$2.9K -22 Closed
PWMG
369
Private Wealth Management Group
New Jersey
– -$2.9K -22 Closed
CSPIA
370
Cary Street Partners Investment Advisory
Virginia
– -$2.64K -20 Closed
MAM
371
Meeder Asset Management
Ohio
– -$2.64K -20 Closed
MG
372
Mather Group
Illinois
– -$2.51K -19 Closed
APW
373
Aventura Private Wealth
Florida
– -$2.38K -18 Closed
LFG
374
Larson Financial Group
Missouri
– -$2.24K -17 Closed
PWA
375
Provenance Wealth Advisors
Florida
– -$2.11K -16 Closed
12 13 14
15
16

ITCI Hedge Fund Activity: Q2 2025 in Review

4 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q2 2025, worth a combined $4.15M — down 100% from $13.6B a quarter earlier.

Sellers outnumbered buyers: 389 funds closed out of ITCI and 0 opened new positions — a net loss of 389 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $1.26B sold.

  • 4 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q2 2025, down from 395 in Q1 2025.
  • Funds reported $4.15M of Intra-Cellular Therapies Inc. stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Intra-Cellular Therapies Inc. positions in Q2 2025 and 389 closed out, a net change of -389 holders.
  • The largest Intra-Cellular Therapies Inc. seller in Q2 2025 was Vanguard Group, an estimated $1.26B sold.

Based on aggregated 13F filings for Q2 2025.